Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms

We compared the performance of two 96-well multiplex immunoassay platforms in assessing plasma cytokine concentrations in patients with glioblastoma (GBM; n = 27), individuals with melanoma, breast or lung cancer metastases to the brain (n = 17), and healthy volunteers (n = 11). Assays included a be...

Descripción completa

Detalles Bibliográficos
Autores principales: Bender, Diane Elizabeth, Schaettler, Maximilian O, Sheehan, Kathleen CF, Johanns, Tanner M, Dunn, Gavin P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013708/
https://www.ncbi.nlm.nih.gov/pubmed/33854293
http://dx.doi.org/10.1177/11772719211006666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013708/
https://www.ncbi.nlm.nih.gov/pubmed/33854293
http://dx.doi.org/10.1177/11772719211006666

Ejemplares similares